Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL VIROLOGY
Volume 87, Issue 10, Pages 1656-1661
Publisher
Wiley
Online
2015-05-06
DOI
10.1002/jmv.24237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Serum Levels of Norovirus Genotype-Specific Blocking Antibodies Correlate With Protection From Infection in Children
- (2014) M. Malm et al. JOURNAL OF INFECTIOUS DISEASES
- Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults
- (2014) D. I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays
- (2014) Hanni Uusi-Kerttula et al. MICROBES AND INFECTION
- Proposal for a unified norovirus nomenclature and genotyping
- (2013) Annelies Kroneman et al. ARCHIVES OF VIROLOGY
- Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland
- (2013) Maria Hemming et al. EUROPEAN JOURNAL OF PEDIATRICS
- Emergence of New Pandemic GII.4 Sydney Norovirus Strain Correlates With Escape From Herd Immunity
- (2013) Kari Debbink et al. JOURNAL OF INFECTIOUS DISEASES
- The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012
- (2013) John-Sebastian Eden et al. VIROLOGY
- Predicting Susceptibility to Norovirus GII.4 by Use of a Challenge Model Involving Humans
- (2012) R. Frenck et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation
- (2012) Lisa C. Lindesmith et al. PLoS Pathogens
- Norovirus Immunity and the Great Escape
- (2012) Kari Debbink et al. PLoS Pathogens
- Prevalence of norovirus GII-4 antibodies in Finnish children
- (2011) K. Nurminen et al. JOURNAL OF MEDICAL VIROLOGY
- Genetic Mapping of a Highly Variable Norovirus GII.4 Blockade Epitope: Potential Role in Escape from Human Herd Immunity
- (2011) K. Debbink et al. JOURNAL OF VIROLOGY
- Norovirus Vaccine against Experimental Human Norwalk Virus Illness
- (2011) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009–2010
- (2011) Leena Puustinen et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Norovirus–host interaction: Multi-selections by human histo-blood group antigens
- (2011) Ming Tan et al. TRENDS IN MICROBIOLOGY
- Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis
- (2011) Vesna Blazevic et al. VACCINE
- A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles
- (2010) L. Huhti et al. ARCHIVES OF VIROLOGY
- Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis
- (2010) Amanda Reeck et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic and Phenotypic Characterization of GII-4 Noroviruses That Circulated during 1987 to 2008
- (2010) Y. Yang et al. JOURNAL OF VIROLOGY
- Real-world Impact of Rotavirus Vaccination
- (2010) Manish M. Patel et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Model systems for the study of human norovirus biology
- (2009) Surender Vashist et al. Future Virology
- Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding
- (2009) David J Allen et al. Virology Journal
- Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations
- (2008) Eric F. Donaldson et al. IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started